Advances on research of metabolomics in malignant cancer diagnosis

doi:10.3969/j.issn.1674-490X.2016.03.009

Abstract

Abstract: Metabolomics for biological metabolite changes was widely accepted,the study of metabolomics is becoming a powerful tool for disease diagnosis and disease mechanism in recent years.In this paper,we review the recent applications of metabonomics study in the diagnosis of malignant tumor.Literatures about the study of metabonomics in the diagnosis of malignant tumor were summarized according to the classification of tumors.In recent years,metabolomics is widely used in cancer diagnosis,mainly in gastric cancer,liver cancer,lung cancer,esophageal cancer,breast cancer,ovarian cancer,prostate cancer,et al.Metabolomics play important role in the aspects of cancer pathogenesis,early diagnosis,differential diagnosis,staging and prognosis.With the development of analysis techniques,metabolomics will become an important method in the research of malignant tumor.

Key words: metabolomics, cancer, diagnosis, review

CLC Number:

LI Yumeng,CHEN Ying. Advances on research of metabolomics in malignant cancer diagnosis[J]. Medical Reserch and Education, 2016, 33(3): 42-46.

References

[1] WU H,XUE R Y,TANG Z Q,et al.Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry[J].Anal Bioanal Chem,2010,396: 1385-1395.DOI:10.1007/s00216-009-3317-4.
[2] ZHANG Y,REN H,JIANG Y,et al.Urinary metabonomics of stomach cancer assessed by rapid resolution liquid chromatography/time-of-flight mass spectrometry[J].Chinese Medical Journal,2013,126(10): 1930-1933.DOI:10.3760/cma.j.issn.0366-6999.20111240.
[3] LIANG Q,WANG C,LI B,et al.Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer [J].Appl Biochem Biotechnol.2015,176(8): 2170-2184.DOI:10.1007/s12010-015-1706-z.
[4] XIAO J F,RENCY V S,ZHOU B,et al.LC-MS Based Serum Metabolomics for Identification of Hepatocellular Carcinoma Biomarkers in Egyptian Cohort[J].J Proteome Res.2012,11(12): 5914-5923.DOI:10.1021/pr300673x.
[5] HUANG Q,TAN Y X,YIN P Y,et al.Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics[J].Cancer Research,2013,73: 4992-5002.DOI:10.1158/0008-5472.CAN-13-0308.
[6] LIU Y,HONG Z Y,TANG G G,et al.NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis[J].Int J Cancer,2014,135(3):658-668.DOI:10.1002/ijc.28706.
[7] XU X,CHENG S,DING C,et al.Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method.[J].Mol Med Rep,2015,11(3):2191-2198.DOI:10.3892/mmr.2014.2973.
[8] 彭媛,刘冉,李晓波,等.应用LC/TOF-MS分析食管鳞状细胞癌血浆小分子代谢物的实验研究[J].癌变·畸变·突变,2013,25(6):412-421.DOI:10.3969/j.issn.1004-616x.2013.06.002.
[9] LIU R,PENG Y,LI X B,et al.Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform[J].Int J Mol Sci,2013,14:8899-8911.DOI:10.3390/ijms14058899.
[10] WU M H,XUE Y,WILLIAM L,et al.Liquid chromatography/mass spectrometry methods for measuring dipeptide abundance in non-small-cell lung cancer[J].Rapid Commun Mass Spectrom,2013,27(18):2091-8.DOI:10.1002/rcm.6656.
[11] 牛艳洁,江银玲,许长江,等.代谢组学方法分析肺癌患者血清和尿液小分子代谢产物的初步研究[J].中国肺癌杂志.2012,15(4):195-201.DOI:10.3779/j.issn.1009-3419.2012.04.01.
[12] 余欣尉,吴谦,吕望,等.基于液相色谱-质谱联用技术的肺癌细胞代谢组学分析[J].色谱.2013,31(7):691-696.DOI:10.3724/SP.J.1123.2012.12039.
[13] MIYAMOTS S,TAYLOR S L,BARUPAL D K,et al.Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry [J].Metabolites,2015,5(2):192-210.DOI:10.3390/metabo5020192.
[14] BUDCZIES J,BROCKMLLER S F,MÜLLER B M,et al.Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism[J].J Proteomics,2013,94:279-88.DOI:10.1016/j.jprot.2013.10.002.
[15] JOBARD E,PONTOIZEAU C,BLAISE B J,et al.A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer[J].Cancer Lett,2014,343(1):33-41.DOI:10.1016/j.canlet.2013.09.011.
[16] QIU Y P,ZHOU B,SU M,et al.Mass Spectrometry-Based Quantitative Metabolomics Revealed a Distinct Lipid Profile in Breast Cancer Patients[J].Int.J.Mol.Sci,2013,14:8047-8061.DOI:10.3390/ijms.14048047.
[17] XIE G,ZHOU B,ZHAO A,et al.Lowered circulating aspartate is a metabolic feature of human breast cancer[J].Oncotarget,2015,6(32):33369-33381.DOI:10.18632/oncotarget.5409.
[18] FAN L J,ZHANG W,YING M Z,et al.Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform[J].Acta Oncologica,2012,51: 473-479.DOI:10.3109/0284186X.2011.648338.
[19] ZHANG T,WY X,KE C,et al.Identification of potential biomarkers for ovarian cancer by urinary metabilomic profiling[J].J Protwome Res,2013,12(1):505-512.DOI:10.1021/pr3009572.
[20] KAUSHIK A K,VAREED S K,BASU S,et al.Metabolomic Profiling Identifies Biochemical Pathways Associated with Castration-Resistant Prostate Cancer[J].J Proteome Res,2014,13(2),1088-1100.DOI:10.1021/pr401106h.
[21] MCDUNN J E,LI Z,ADAM K P,et al.Metabolomic signatures of aggressive prostate cancer[J].Prostate,2013,73(14):1547-60.DOI:10.1002/pros.22704.
[22] ZHANG T,DAVID G W,WANG L J,et al.Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery[J].PLoS One,2013,8(6):10454-10461.DOI:10.1371/journal.pone.0065880.